032003429 | PUO | 50415670 | | 9990182 | 7/24/2006 12:00:00 AM | Coronary artery disease 414.01 | | DIS | Admission Date: 6/5/2006 Report Status: 

Discharge Date: 10/23/2006 ****** FINAL DISCHARGE ORDERS ****** BEEBEE , MINNIE 809-39-21-7 Pla Las Hisdence Service: CAR DISCHARGE PATIENT ON: 10/19/06 AT 02:00 PM CONTINGENT UPON Attending evaluation WILL D/C ORDER BE USED AS THE D/C SUMMARY: YES Attending: KUSH , QUINN J. , M.D. CODE STATUS: Full code DISPOSITION: Home DISCHARGE MEDICATIONS: ENTERIC COATED ASA 325 MG PO DAILY TESSALON PERLES ( BENZONATATE ) 100 MG PO TID PRN Shortness of Breath Number of Doses Required ( approximate ): 6 PLAVIX ( CLOPIDOGREL ) 75 MG PO DAILY Starting IN AM ( 8/2 ) CODEINE PHOSPHATE 15 MG PO Q3H PRN Pain HOLD IF: sedated , rr&lt;12 DEXTROMETHORPHAN HBR 10 MG PO Q6H PRN Other:cough HOLD IF: sedated , rr&lt;12 Number of Doses Required ( approximate ): 6 ZETIA ( EZETIMIBE ) 10 MG PO DAILY LANTUS ( INSULIN GLARGINE ) 20 UNITS SC BEDTIME HOLD IF: call HO if BG &lt;90 POTASSIUM CHLORIDE IMMED. 
REL. ( KCL IMMEDIATE... ) *** LOW KCL REPLACEMENT SCALE ORAL PO Scale Frequency 1. 
Only KCL Immediate Release products may be used for KCL scales. 
2. Do not use sustained-release potassium for KCL scale doses. 
3. Replace KCL based on lab values. 
4. As per PUO Potassium Chloride Policy: each 20 mEq dose is to be given with 4oz of fluid. 
5.A serum creatinine must be ordered and checked daily while patient is ordered for a K-scale. 
6.K-scale cannot be used on patients with: * A serum creatinine greater than or equal to 2.0 mg/dl; or * A serum creatinine increase of 0.5 mg/dl within 24 hours. 
* Hold scale and contact MD if SCr is greater than 2.0. 
----------------------------------------------------------- ----------- If K+ Level is less than 3.1 then call H.O. 
If K+ Level is 3.1-3.3 
, then administer KCL 40 meq orally followed by 20 meq orally 2 hours later. 
Recheck K+ Level 2 hours after dose was given. 
If K+ Level is 3.4-3.6 
, then administer KCL 40 meq orally Recheck K+ Level 2 hours after dose was given. 
If K+ Level is 3.7-4.0 
, then administer KCL 20 meq orally Recheck K+ Level 2 hours after dose was given. 
If K+ Level is 4.1-5.0 , then DO NOT administer KCL. 
Recheck K+ Level in QAM If K+ Level is greater than 5.0 then call H.O. ----------------------------------------------------------- ----------- Override Notice: Override added on 10/19/06 by BALDAUF , WILLOW N. , M.D. on order for DIOVAN PO ( ref # 269432644 ) POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; VALSARTAN Reason for override: aware MAALOX-TABLETS QUICK DISSOLVE/CHEWABLE 1-2 TAB PO Q6H PRN Upset Stomach MAGNESIUM GLUCONATE Sliding Scale PO ( orally ) DAILY -&gt; Mg-scales cannot be used and magnesium doses must be individualized for patients who have: - a serum creatinine greater than or equal to 2.0 mg/dL; or - a serum creatinine greater than or equal to 1.5 mg/dL and an increase of 0.5mg/dL within 24 hours. 
Call HO if Mg level is less than 0.8 If Mg level is less than 1 , then give 3 gm Mg Gluconate orally and call HO If Mg level is 1.0-1.5 , then give 2 gm Mg Gluconate orally If Mg level is 1.6-1.9 , then give 1 gm Mg Gluconate orally If Mg level is 2.0-2.5 , then Do Not administer Mg Gluconate Call HO if Mg level is greater than 2.5 NITROGLYCERIN 1/150 ( 0.4 MG ) 1 TAB SL q5min x 3 PRN chest pain HOLD IF: SBP &lt; 100 OXYCODONE 5-10 MG PO Q6H PRN Pain PINDOLOL 5 MG PO BID HOLD IF: sbp&lt;90 , HR&lt;50 Food/Drug Interaction Instruction Take consistently with meals or on empty stomach. 
ZOCOR ( SIMVASTATIN ) 80 MG PO BEDTIME Food/Drug Interaction Instruction Avoid grapefruit unless MD instructs otherwise. 
DIOVAN ( VALSARTAN ) 160 MG PO DAILY Starting IN AM ( 1/20 ) Alert overridden: Override added on 10/19/06 by BALDAUF , WILLOW N. , M.D. POTENTIALLY SERIOUS INTERACTION: POTASSIUM CHLORIDE &amp; VALSARTAN Reason for override: aware Number of Doses Required ( approximate ): 5 DIET: House / Low chol/low sat. 
fat DIET: House / ADA 2100 cals/dy DIET: 2 gram Sodium ACTIVITY: Walking as tolerated Lift restrictions: Do not lift greater then 15 pounds FOLLOW UP APPOINTMENT( S ): Dr. Kush He will arrange. 
, ALLERGY: NKA ADMIT DIAGNOSIS: Elective cardiac catheterization with PCI PRINCIPAL DISCHARGE DIAGNOSIS ;Responsible After Study for Causing Admission ) Coronary artery disease 414.01 OTHER DIAGNOSIS;Conditions , Infections , Complications , affecting Treatment/Stay CAD OPERATIONS AND PROCEDURES: Cardiac catheterization with stent to old CABG vessel OTHER TREATMENTS/PROCEDURES ( NOT IN O.R. ) CXR BRIEF RESUME OF HOSPITAL COURSE: CC: Elective Cardiac Cath HPI: 58 yo female smoker with hx of CAD , s/p CABG x3 , DM II , HTN , and hyperlipidemia admitted to the CCU after elective cardiac cath s/p abnormal stress test. 
Cath showed impaired flow in the inferior and posterolateral zones due to obstructive degenerative disease in the SVGs to the RCA and LCF-OM. 
Stent placed in the RCA graft though there was extensive calcification and difficulty obtaining full stent expansion , and following the stent deployment there was poor reflow accompanied by mild chest pain and EKG changes , without hemodynamic embarrassment. 
Pt was transferred back to the CCU stable and without pain. 
Pt was scheduled for call out to floor , but had an episode of jaw sensation , different from previous angina. 
Pt was upset by turn of events , but was calmed by staff. 
Was then evaluated by Dr. Kush and came out to the floor Na night. 
PMH DMII , HTN , Hyperlipidemia , Cirrhosis s/p CABG x 3 1997 s/p AAA repair 1996 s/p aorto-fem bypass 1996 s/p TAHBSO Meds Lantus 40u qd Estradiol 0.05 Diltiazem 180 mg qd HCTZ 25 mg qd Zetia 10mg qd Diovan 160 mg qd Plavix 75 mg qd Zocor 80 mg qd ASA 325 mg qd MV Meds in CCU ASA 325 mg qd Lantus 20u qd Plavix 75 mg qd Zetia 10mg qd Famotidine 20 mg BID Pindolol 5 mg BID Lovenox 40 sc qd nicotine patch MgSO4 SS KCL SS Novolog SS Pt Status Vitals Gen - Awake , Alert , NAD HEENT - JVP 6 cm , No bruits Chest - CTAB with mild rhonchi/wheezes R&gt;L CV - RRR , Nml S1 , S2 , II/VI SEM at LLSB Abd - Soft , NT , ND , No organomegaly Extr - L femoral bruit , R cath site , oozing , no edema , hematoma , ecchymosis present Studies CAth - Right Dominant Circulation Left Main Coronary Artery No significant LM lesions identified Left Anterior Descending Artery LAD ( Proximal ) , Discrete 90% lesion LAD ( Ostial ) , Discrete 90% lesion Left Circumflex Artery CX ( Proximal ) , Discrete 90% lesion Right Coronary Artery RCA ( Proximal ) , Discrete 100% lesion RT PDA ( Mid ) , Discrete 100% lesion Coronary Artery Bypass Grafts: SVG Graft to RT PDA ( Mid ) , Discrete 90% lesion STENT to 20% LIMA Graft to LAD SVG Graft to MARG1 ( Ostial ) , Discrete 90% lesion SVG Graft to MARG1 ( Proximal ) , Discrete 90% lesion Collateral flow from LAD to RT PDA A/P 1. Cardiac Ischemia- Pt had elective PCI on 9/6/06 with results as mentioned previously. 
She did experience jaw sensations and chest pain post procedure that she describes as different from periprocedure pain , and previous episodes of angina. 
After release from CCU , had no further events. 
No current chest or jaw pain. 
Continuing plavix , zocor , zetia as outpt and heparin and Integrelin have been discontinued. 
Pump- PT has preserved fxn , BP low normal , pt euvolemic. 
Rhythm - NSR on telemetry will d/c on Betablocker. 
2. Pulm - Pt has chronic cough due to Post nasal drip. 
Taken off of her antihistamine on admission. 
It is USOH per pt. 
DID NOT GIVE ANTIHISTAMINES in this hospital course. 
CXR was normal with no acute changes on admission. 
3. Renal - NO hx of renal dz , No renal issues during hospital course. 
4. Endo - DMII on Lantus , Novolog SS , while in the hospital. 
FS Glu monitored. 
No adjustment needed. 
Will send out on home doses o insulin. 
5. Heme - Pt had cath and subsequent oozing from site in groin. 
Hct was stable post cath , Anticoagulation stopped. 
Pt to be discharged on home meds including plavix and ASA. 
ADDITIONAL COMMENTS: Please return if you have any chest pain , jaw pain , shortness of breath , groin pain , groin swelling , dizziness , or fever and chills. 
Please take medicines as previously prescribed. 
Please limit activity for the next few day to non-strenuous work. 
Please make follow up appts. 
with primary care physician and cardiologist within the next 2 weeks. 
DISCHARGE CONDITION: Stable TO DO/PLAN: Please follow up on groin site and evaluate for bruits or hematoma. 
Please follow Hct to ensure no acute blood loss. 
No dictated summary ENTERED BY: KUSH , QUINN J. , M.D. ( PQ5 ) 10/19/06 @ 05:01 PM REVIEWED BY: KUSH , QUINN J. , M.D. ****** END OF DISCHARGE ORDERS ******